Global Endoscopic Ultrasound Needles Market Size, Share and Trends Analysis Report – Industry Overview and Forecast to 2033

Endoscopic Ultrasound Needles Market Size

• The global endoscopic ultrasound needles market size was valued at USD 182.86 million in 2025 and is expected to reach USD 255.50 million by 2033, at a CAGR of 4.27% during the forecast period
• The market growth is largely fueled by the rising prevalence of gastrointestinal and other chronic diseases, increasing utilization of endoscopic ultrasound procedures, and continuous technological advancements in needle design that enhance precision, safety, and clinical outcomes during tissue sampling
• Furthermore, growing adoption of minimally invasive diagnostic and therapeutic procedures in both hospitals and specialized clinics, along with rising healthcare expenditure and expanding healthcare infrastructure globally, is driving demand for endoscopic ultrasound needles as essential tools for accurate diagnostics and early disease detection

Endoscopic Ultrasound Needles Market Analysis

• Endoscopic ultrasound needles, used for minimally invasive tissue sampling and diagnostic procedures, are increasingly vital in modern gastroenterology, pulmonology, and oncology practices due to their precision, safety, and integration with advanced imaging technologies
• The escalating demand for endoscopic ultrasound needles is primarily fueled by the rising prevalence of gastrointestinal, pancreatic, and other chronic diseases, growing adoption of minimally invasive diagnostic procedures, and continuous advancements in needle design that improve clinical outcomes
• North America dominated the endoscopic ultrasound needles market with the largest revenue share of 39.2% in 2025, driven by advanced healthcare infrastructure, high adoption of innovative medical devices, and a strong presence of leading market players. The U.S. experienced substantial growth due to increasing awareness, early diagnosis initiatives, and widespread adoption of EUS-guided procedures
• Asia-Pacific is expected to be the fastest growing region in the endoscopic ultrasound needles market during the forecast period due to expanding healthcare infrastructure, rising healthcare expenditure, and growing awareness about minimally invasive diagnostic procedures
• Biopsy needles (EUS-FNB) segment dominated the market with a share of 44.9% in 2025, driven by their effectiveness in obtaining tissue samples, improved diagnostic accuracy, and increasing preference in both hospitals and specialty clinics

Report Scope and Endoscopic Ultrasound Needles Market Segmentation    

Endoscopic Ultrasound Needles Market Trends

Technological Advancements in Needle Design and Imaging Integration

• A significant and accelerating trend in the global endoscopic ultrasound needles market is the continuous advancement of needle design and integration with high-resolution imaging systems, enhancing diagnostic accuracy and procedural safety
  • For instance, fine-needle biopsy (EUS-FNB) devices with core tissue acquisition capabilities allow clinicians to obtain larger tissue samples with minimal trauma, improving diagnostic outcomes
• Needle designs integrated with elastography or contrast-enhanced EUS imaging enable more precise targeting of lesions, allowing physicians to differentiate tissue types and optimize sampling locations
• Integration with robotic-assisted and AI-guided endoscopic platforms facilitates more controlled, precise needle placement, reducing procedural complications and enhancing clinician confidence
• This trend towards smarter, more precise, and image-integrated needles is reshaping clinician expectations, with companies such as Boston Scientific developing AI-assisted EUS-FNB needles for improved tissue acquisition and procedure efficiency
• The demand for advanced endoscopic ultrasound needles that combine enhanced design, imaging compatibility, and minimally invasive functionality is growing across hospitals and specialty clinics globally
• Increasing collaboration between needle manufacturers and imaging solution providers is enabling the development of fully integrated EUS systems, providing clinicians with streamlined procedural workflows
• Rising adoption of single-use and disposable needles to reduce infection risks and enhance patient safety is becoming a noteworthy trend across developed and emerging markets

Endoscopic Ultrasound Needles Market Dynamics

Driver

Rising Prevalence of Gastrointestinal and Pancreatic Diseases

• The increasing incidence of gastrointestinal, pancreatic, and other chronic diseases, combined with growing awareness of early diagnosis, is a significant driver for heightened demand for endoscopic ultrasound needles
  • For instance, in 2025, Cook Medical launched advanced EUS-FNB needles aimed at improving diagnostic accuracy in pancreatic lesions, expected to drive adoption in hospitals and specialty clinics
• Clinicians prefer minimally invasive tissue sampling procedures that reduce patient risk and recovery time, making EUS-guided procedures more attractive than surgical biopsies
• The rising focus on early detection and precision medicine has made EUS-guided biopsy a standard in gastroenterology and oncology practices, driving needle utilization
• Hospitals and specialty clinics are increasingly investing in advanced EUS equipment and needles, further propelling market growth
• Growing insurance coverage and reimbursement policies for minimally invasive diagnostic procedures are encouraging hospitals to adopt EUS-guided tissue sampling more widely
• Increasing awareness among patients and physicians about the benefits of early and accurate disease diagnosis is further fueling the uptake of advanced EUS needles

Restraint/Challenge

High Procedure Cost and Limited Skilled Professionals

• The high cost of endoscopic ultrasound procedures, including the price of advanced needles, can limit adoption, especially in developing regions or smaller healthcare facilities
  • For instance, in some emerging markets, hospitals face budget constraints that restrict the procurement of premium EUS-FNB and FNA devices, slowing market penetration
• A shortage of trained endoscopists capable of performing complex EUS-guided procedures poses a significant challenge for market expansion
• Training programs for specialized EUS procedures are time-intensive and costly, limiting the number of healthcare professionals qualified to use advanced needles
• Overcoming these barriers through cost-effective needle solutions, wider clinician training, and adoption support programs will be crucial for sustained market growth
• Variability in regulatory approvals across regions can delay product launches and limit accessibility of newer, more advanced needles in certain markets
• Poor awareness or skepticism among smaller clinics regarding the clinical advantages of advanced EUS needles may hinder market penetration in some regions

Endoscopic Ultrasound Needles Market Scope

The market is segmented on the basis of product type, application, and end user.

• By Product Type

On the basis of product type, the market is segmented into Biopsy Needles (EUS-FNB) and Aspiration Needles (EUS-FNA). The Biopsy Needles (EUS-FNB) segment dominated the market with the largest revenue share of 44.9% in 2025, driven by their ability to obtain core tissue samples with higher diagnostic accuracy compared to conventional aspiration needles. Clinicians prefer FNB needles for histological examination, which provides better insights for disease staging and treatment planning, particularly in pancreatic and gastrointestinal cancers. The segment benefits from continuous technological advancements, such as improved needle tip design and compatibility with high-resolution imaging systems. Hospitals and specialty clinics favor FNB needles due to their enhanced safety profile and ability to reduce repeat procedures. The segment also sees strong demand in regions with advanced healthcare infrastructure, where minimally invasive diagnostic procedures are prioritized. Overall, EUS-FNB needles are considered essential tools in modern endoscopic practice for accurate and reliable tissue acquisition.

The Aspiration Needles (EUS-FNA) segment is expected to witness the fastest growth rate of 7.2% CAGR from 2026 to 2035, fueled by their widespread adoption in emerging markets due to lower costs and simpler operation. FNA needles are extensively used for cytological evaluation and fine-needle sampling of lesions, making them an attractive option for outpatient clinics and ambulatory surgical centers. Growing awareness among clinicians about the diagnostic efficiency of FNA needles, combined with rising incidence of gastrointestinal and pancreatic diseases, is accelerating adoption. Continuous innovation in FNA needle design, such as enhanced flexibility and reduced tissue trauma, is also contributing to market growth. In addition, healthcare providers are increasingly incorporating FNA needles into routine diagnostic workflows due to their safety and efficiency. The segment’s affordability and accessibility make it an essential choice for regions with constrained healthcare budgets.

• By Application

On the basis of application, the market is segmented into enteral needles and bronchial needles. The Enteral Needles segment dominated the market in 2025, capturing the largest revenue share of 55%, primarily due to its extensive use in gastrointestinal diagnostics and interventions. Enteral needles are commonly employed for pancreatic, liver, and gastrointestinal lesion sampling, which are high-prevalence areas for chronic diseases and cancers. Their compatibility with EUS-guided imaging systems allows clinicians to accurately target lesions and minimize procedural complications. Hospitals and specialty clinics prefer enteral needles for routine endoscopic procedures because of their versatility and reliability. Continuous technological improvements in tip design, echogenic markings, and needle flexibility enhance their performance and safety. The strong adoption of enteral needles in North America and Europe further reinforces their dominant market position.

The Bronchial Needles segment is expected to witness the fastest growth rate of 7.5% CAGR from 2026 to 2035, driven by the rising prevalence of lung and mediastinal disorders requiring minimally invasive tissue sampling. Bronchial needles are increasingly used in pulmonary interventions for early detection of lung cancers and other thoracic conditions. Technological advancements such as improved maneuverability and compatibility with endobronchial ultrasound systems are boosting clinician confidence. The segment’s growth is further supported by the expansion of specialty pulmonary clinics and increasing healthcare expenditure in Asia-Pacific and Latin America. In addition, the trend toward minimally invasive procedures in respiratory medicine is driving higher adoption. Rising awareness among pulmonologists and improved reimbursement policies also contribute to the segment’s rapid growth.

• By End User

On the basis of end user, the market is segmented into ambulatory surgical centers, specialty clinics, hospitals, and others. The Hospitals segment dominated the market in 2025, holding the largest revenue share of 60%, due to the high volume of diagnostic and therapeutic EUS procedures conducted in hospital settings. Hospitals have the required infrastructure, advanced imaging systems, and trained endoscopists to perform complex procedures using FNB and FNA needles. The preference for hospitals is also driven by the need for accurate staging and diagnosis of chronic and cancerous conditions. Hospitals benefit from multi-disciplinary collaboration, which enhances the adoption of specialized needles. North America and Europe, with well-established healthcare infrastructure, continue to drive the dominance of hospitals as primary end users. Continuous investment in EUS technology and training programs further strengthens this segment.

The Specialty Clinics segment is expected to witness the fastest growth rate of 8% CAGR from 2026 to 2035, fueled by the increasing number of outpatient and minimally invasive diagnostic centers. Specialty clinics are adopting advanced needles due to growing patient preference for quicker, less invasive procedures with shorter recovery times. Rising awareness of EUS-guided diagnostics among clinicians in gastroenterology and pulmonology is contributing to the segment’s expansion. Technological advancements that allow needle compatibility with compact imaging systems make specialty clinics an ideal growth area. In addition, increasing healthcare expenditure in Asia-Pacific and Latin America is accelerating adoption in these clinics. The focus on cost-effective, efficient procedures further supports the rapid growth of this segment.

Endoscopic Ultrasound Needles Market Regional Analysis

• North America dominated the endoscopic ultrasound needles market with the largest revenue share of 39.2% in 2025, driven by advanced healthcare infrastructure, high adoption of innovative medical devices, and a strong presence of leading market players
• Hospitals and specialty clinics in the region increasingly rely on EUS-FNB and FNA needles for accurate tissue sampling in gastrointestinal, pancreatic, and thoracic disorders, owing to their precision, safety, and compatibility with high-resolution imaging systems
• The strong market presence is further supported by rising healthcare expenditure, technological innovations by leading medical device companies, and early adoption of AI-assisted and image-integrated needle systems, establishing endoscopic ultrasound needles as essential diagnostic tools in North America

U.S. Endoscopic Ultrasound Needles Market Insight

The U.S. endoscopic ultrasound needles market captured the largest revenue share of 82% in North America in 2025, driven by high adoption of minimally invasive diagnostic procedures and advanced healthcare infrastructure. Hospitals and specialty clinics are increasingly relying on EUS-FNB and FNA needles for precise tissue sampling in gastrointestinal, pancreatic, and thoracic disorders. The growing trend of early diagnosis and precision medicine, combined with strong reimbursement policies and awareness among clinicians, is further propelling market growth. In addition, integration with high-resolution imaging systems and AI-assisted devices is enhancing procedural accuracy and efficiency, establishing the U.S. as the leading market in the region.

Europe Endoscopic Ultrasound Needles Market Insight

The Europe endoscopic ultrasound needles market is projected to expand at a substantial CAGR during the forecast period, driven by rising prevalence of gastrointestinal and pancreatic diseases and increasing demand for minimally invasive procedures. Growing healthcare expenditure, technological advancements in needle design, and a focus on early cancer diagnosis are fostering adoption across hospitals and specialty clinics. European clinicians are increasingly integrating EUS needles with advanced imaging platforms to improve procedural outcomes. The market also benefits from well-established healthcare infrastructure, multi-disciplinary endoscopy centers, and government initiatives supporting innovative diagnostic technologies.

U.K. Endoscopic Ultrasound Needles Market Insight

The U.K. endoscopic ultrasound needles market is expected to grow at a noteworthy CAGR during the forecast period, fueled by increasing incidence of gastrointestinal and thoracic diseases and the adoption of minimally invasive diagnostics. Hospitals and specialty clinics are expanding their use of EUS-FNB and FNA needles due to their effectiveness in tissue acquisition and procedural safety. The trend toward outpatient and ambulatory diagnostic centers, coupled with government support for advanced medical technologies, is encouraging adoption. In addition, growing awareness among clinicians and patients about early detection benefits is stimulating market growth.

Germany Endoscopic Ultrasound Needles Market Insight

The Germany endoscopic ultrasound needles market is anticipated to expand at a considerable CAGR during the forecast period, driven by technological advancements in needle design and high adoption of EUS procedures in hospitals and specialty clinics. Rising awareness regarding early disease diagnosis, coupled with Germany’s focus on innovation and healthcare quality, promotes the use of advanced EUS-FNB and FNA needles. Integration with imaging systems and AI-assisted devices is increasingly prevalent, providing improved procedural outcomes. The strong healthcare infrastructure, emphasis on precision medicine, and adoption in both diagnostic and therapeutic applications contribute to market growth.

Asia-Pacific Endoscopic Ultrasound Needles Market Insight

The Asia-Pacific endoscopic ultrasound needles market is poised to grow at the fastest CAGR of 8% during the forecast period of 2026 to 2035, fueled by rising incidence of gastrointestinal and pancreatic diseases, expanding healthcare infrastructure, and increasing awareness about minimally invasive diagnostics. Countries such as China, Japan, and India are witnessing rapid adoption of EUS-guided procedures in hospitals and specialty clinics. Government initiatives promoting healthcare modernization, along with rising disposable incomes, are enhancing access to advanced needles. Technological improvements and cost-effective solutions are further facilitating market penetration in both urban and semi-urban regions.

Japan Endoscopic Ultrasound Needles Market Insight

The Japan endoscopic ultrasound needles market is gaining momentum due to the country’s advanced healthcare infrastructure, high awareness of minimally invasive diagnostics, and strong demand for precision medicine. Hospitals and specialty clinics are increasingly integrating EUS-FNB and FNA needles with imaging systems and AI-assisted devices to enhance diagnostic accuracy. Rapid urbanization, increasing patient preference for outpatient procedures, and growing focus on early disease detection are supporting market expansion. In addition, the aging population is driving demand for safer and more convenient tissue sampling solutions in both residential and clinical healthcare settings.

India Endoscopic Ultrasound Needles Market Insight

The India endoscopic ultrasound needles market accounted for the largest revenue share in Asia-Pacific in 2025, driven by rising prevalence of gastrointestinal diseases, expanding healthcare infrastructure, and growing number of specialty clinics performing minimally invasive procedures. Hospitals and clinics are increasingly adopting EUS-FNB and FNA needles due to their affordability, safety, and procedural efficiency. Government initiatives promoting healthcare modernization and smart hospital projects are further supporting adoption. In addition, rising patient awareness, expanding private healthcare networks, and availability of cost-effective devices are key factors propelling market growth in India.

Endoscopic Ultrasound Needles Market Share

The Endoscopic Ultrasound Needles industry is primarily led by well-established companies, including:

• Olympus Corporation (Japan)
• Boston Scientific Corporation (U.S.)
• Cook (U.S.)
• Medtronic (Ireland)
• CONMED Corporation (U.S.)
• Medi Globe GmbH (Germany)
• ACE Medical Devices Pvt. Ltd. (India)
• FUJIFILM Holdings Corporation (Japan)
• HOYA Corporation (Japan)
• B. Braun SE (Germany)
• Steris plc (U.S.)
• Endo Flex GmbH (Germany)
• Limaca Medical Ltd. (Israel)
• Medorah Meditek Pvt. Ltd. (India)
• Zhejiang Soudon Medical Technology Co., Ltd. (China)
• SonoScape Medical Corp. (China)
• BD (U.S.)
• Argon Medical Devices, Inc. (U.S.)
• Terumo Corporation (Japan)
• Glowtronics Medical (India)

What are the Recent Developments in Global Endoscopic Ultrasound Needles Market?

• In October 2025, Olympus Corporation announced the launch of its SecureFlex single‑use fine needle biopsy device designed for endoscopic ultrasound‑guided fine needle biopsy (EUS‑FNB) of submucosal and extramural gastrointestinal lesions. The device features a dual‑beveled Raptor tip and flexible nitinol construction to help clinicians collect larger, intact tissue samples with improved access to complex anatomy, aiding diagnosis of diseases such as pancreatic cancer
• In September 2025, the FDA announced a global recall of certain ViziShot 2 FLEX 19G endoscopic aspiration needles used in conjunction with ultrasound systems due to a risk of deformed a‑traumatic tips that could lead to device breakage during procedures. This regulatory action highlights ongoing product safety surveillance and impacts clinical usage decisions
• In February 2025, Limaca Medical Ltd. launched its Precision‑GI™ automated endoscopic ultrasound biopsy device in the U.S. market following FDA 510(k) clearance and CMS transitional pass‑through payment support, bringing an automated, motorized EUS biopsy solution designed to improve biopsy tissue quality and procedural efficiency for gastrointestinal cancers and adjacent organ lesions
• In May 2023, the U.S. FDA granted 510(k) clearance to EchoTip® AcuCore™ Ultrasound Biopsy Needle (ECHO‑BX‑3‑22) by Cook Ireland Ltd., indicating substantial equivalence to existing devices and enabling its use for endoscopic ultrasound‑guided fine needle biopsy (FNB) of gastrointestinal lesions. This regulatory milestone supported broader clinical availability and adoption of the updated biopsy needle technology
• In May 2023, Cook Medical’s EchoTip® AcuCore™ Ultrasound Biopsy Needle received a U.S. FDA 510(k) clearance specifying indications for fine needle biopsy for submucosal and extramural lesions, which supports its use in more varied tissue sampling procedures and helps broaden clinician adoption

SKU-59579